Een verzameling van nieuwsberichten die de afgelopen weken zijn gespot op het internet:
Brexit
- Speed Dating in the UK? Negotiating New Data Protection Relationships with the EU (28 oktober 2020). LexBlog.
- Guidance Procedures for UK Paediatric Investigation Plan (PIPs) from 1 January 2021 (last updated 27 oktober 2020). Medicines and Healthcare products Regulatory Agency.
COVID-19
- Impact of COVID-19 in paediatric early-phase cancer clinical trials in Europe: A report from the Innovative Therapies for Children with Cancer (ITCC) consortium (december 2020). European Journal of Cancer.
- EMA outlines regulatory transparency measures amid COVID pandemic (30 oktober 2020). Regulatory Focus.
- Opinion: For now, it’s unethical to use human challenge studies for SARS-CoV-2 vaccine development (29 oktober 2020). PNAS.
- The ‘very, very bad look’ of remdesivir, the first FDA-approved COVID-19 drug (28 oktober 2020). Science.
- Recommended Checklist for Research Communities During the COVID-19 Pandemic (oktober 2020). UK Research Integrity Office.
- Researchers publish the same COVID-19 paper three times (29 oktober 2020). Retraction Watch.
- Analyze Data Validity to Identify Impact of COVID-19 Disruptions, Expert Says (26 oktober 2020). WCG CenterWatch.
- FDA Advisory Committee to Develop Master Protocols for COVID-19 Vaccines (26 oktober 2020). WCG CenterWatch.
- Watch: mRNA vaccines face their first test in the fight against Covid-19. How do they work? (26 oktober 2020). STAT.
- Binnen drie uur 10.000 aanmeldingen Limburgs corona-onderzoek (23 oktober 2020). Skipr.
- Vaccines 101: How new vaccines are developed (28 september 2020). Nature, via YouTube.
- Immuno-oncology drug development forges on despite COVID-19 (18 september 2020). Nature.
- Russian Covid-19 vaccine data raises questions (11 september 2020). Chemistry World.
Dierexperimenteel onderzoek
Dutch Oncology Research Platform (DORP)
- Clinical Trial Roadmap is compleet (27 oktober 2020).
- Waarom een statisticus vroeg in een studie betrekken? (27 oktober 2020).
EQUATOR Network
- What is the little thing you can do to increase reproducibility, replicability and trust in science? (5 oktober 2020).
- Why did we develop TIDieR-Placebo? (29 september 2020).
Federaal Agentschap voor Geneesmiddelen en Gezondheidsproducten (FAGG)
Ministerie van Economische Zaken en Klimaat & Ministerie van Onderwijs, Cultuur en Wetenschap
Overig nieuws
- Pharmafocus (November 2020).
- ‘Patient friction coefficient’ can gauge the burden of participating in a clinical trial (30 oktober 2020). STAT.
- Euro Convergence: Early consultation critical in overcoming gene therapy hurdles (30 oktober 2020). Regulatory Focus.
- The Stressful Conclusion of a Clinical Trial (29 oktober 2020). The New York Times.
- Wealthy funder pays reparations for use of HeLa cells (29 oktober 2020). Nature.
- Euro Convergence: EMA makes case for multi-stakeholder response to emerging challenges (29 oktober 2020).
- There’s a silent crisis in clinical research. And it’s not Covid-19 (28 oktober 2020). STAT.
- Euro Convergence: Pragmatic approaches to data collection needed to meet MDR (28 oktober 2020). Regulatory Focus.
- Study bystanders and ethical treatment of study participants—A proof of concept (26 oktober 2020). Bioethics.
- Prof. Peter Mol: Bringing regulatory science closer to the shop floor (19 oktober 2020). Regulatory Science, edition 11.
- Richland man who faked human research trials dealt 28-year sentence (1 oktober 2020). YakTriNews.
Volg het laatste nieuws via de nieuwsfeed op het weblog.
Raadpleeg het weblog ook voor een actueel overzicht van bijeenkomsten, evenementen en publieke consultaties.
Nieuwsfeed
> news.bontrop.com <